These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9360571

  • 1. Rapid life-threatening hyperkalemia after addition of amiloride HCl/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy.
    Chiu TF, Bullard MJ, Chen JC, Liaw SJ, Ng CJ.
    Ann Emerg Med; 1997 Nov; 30(5):612-5. PubMed ID: 9360571
    [Abstract] [Full Text] [Related]

  • 2. Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations.
    Johnston RT, de Bono DP, Nyman CR.
    Int J Cardiol; 1992 Feb; 34(2):213-5. PubMed ID: 1737674
    [Abstract] [Full Text] [Related]

  • 3. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF.
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The side effects of angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension].
    Babadzhan VD, Lapshina LA, Shkapo VL.
    Lik Sprava; 2000 Oct; (3-4):54-9. PubMed ID: 10921262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet.
    Hay E, Derazon H, Bukish N, Katz L, Kruglyakov I, Armoni M.
    J Emerg Med; 2002 May; 22(4):349-52. PubMed ID: 12113843
    [Abstract] [Full Text] [Related]

  • 12. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
    Schepkens H, Vanholder R, Billiouw JM, Lameire N.
    Am J Med; 2001 Apr 15; 110(6):438-41. PubMed ID: 11331054
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A.
    Hypertension; 2007 Feb 15; 49(2):276-84. PubMed ID: 17159081
    [Abstract] [Full Text] [Related]

  • 15. Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs.
    Berkova M, Berka Z, Topinkova E.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Feb 15; 158(1):84-91. PubMed ID: 23128820
    [Abstract] [Full Text] [Related]

  • 16. Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
    Mooser V, Waeber G, Bidiville J, Waeber B, Nussberger J, Brunner HR.
    J Clin Hypertens; 1987 Dec 15; 3(4):510-3. PubMed ID: 2839627
    [Abstract] [Full Text] [Related]

  • 17. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep 15; 23(152):215-20. PubMed ID: 25325125
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P, Fuchs FD, Moreira LM, Martins VM, Bertoluci C, Fuchs SC, Gus M.
    Clin Exp Hypertens; 2008 Oct 15; 30(7):553-64. PubMed ID: 18855259
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.